Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 17 studies | 27% ± 12% | |
CD16-negative, CD56-bright natural killer cell, human | 8 studies | 32% ± 17% | |
CD16-positive, CD56-dim natural killer cell, human | 6 studies | 25% ± 11% | |
CD8-positive, alpha-beta T cell | 6 studies | 26% ± 7% | |
exhausted T cell | 4 studies | 32% ± 1% | |
mature NK T cell | 4 studies | 28% ± 9% | |
CD8-positive, alpha-beta memory T cell | 4 studies | 25% ± 9% | |
effector CD8-positive, alpha-beta T cell | 3 studies | 20% ± 2% | |
mucosal invariant T cell | 3 studies | 21% ± 3% | |
T cell | 3 studies | 17% ± 1% |
Insufficient scRNA-seq data for expression of EOMES at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 304.56 | 570 / 578 | 70% | 2.49 | 808 / 1155 |
kidney | 56% | 60.19 | 50 / 89 | 65% | 4.41 | 590 / 901 |
liver | 92% | 111.25 | 208 / 226 | 23% | 0.72 | 95 / 406 |
breast | 56% | 45.10 | 259 / 459 | 58% | 2.53 | 645 / 1118 |
uterus | 59% | 41.98 | 100 / 170 | 41% | 1.55 | 190 / 459 |
spleen | 100% | 1582.23 | 241 / 241 | 0% | 0 | 0 / 0 |
skin | 8% | 4.00 | 138 / 1809 | 89% | 10.37 | 420 / 472 |
stomach | 44% | 29.00 | 158 / 359 | 51% | 2.31 | 145 / 286 |
lymph node | 0% | 0 | 0 / 0 | 93% | 27.44 | 27 / 29 |
bladder | 57% | 51.29 | 12 / 21 | 31% | 0.89 | 158 / 504 |
peripheral blood | 88% | 938.90 | 818 / 929 | 0% | 0 | 0 / 0 |
thymus | 56% | 83.45 | 368 / 653 | 31% | 1.18 | 185 / 605 |
prostate | 55% | 50.60 | 135 / 245 | 29% | 0.87 | 146 / 502 |
tonsil | 0% | 0 | 0 / 0 | 82% | 5.08 | 37 / 45 |
pancreas | 33% | 16.69 | 107 / 328 | 46% | 1.40 | 81 / 178 |
intestine | 39% | 59.08 | 380 / 966 | 37% | 1.19 | 196 / 527 |
adipose | 74% | 100.33 | 888 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 17% | 8.85 | 240 / 1445 | 49% | 1.35 | 90 / 183 |
adrenal gland | 51% | 34.06 | 132 / 258 | 12% | 0.46 | 28 / 230 |
ovary | 19% | 13.02 | 35 / 180 | 33% | 0.75 | 144 / 430 |
eye | 0% | 0 | 0 / 0 | 46% | 2.45 | 37 / 80 |
blood vessel | 46% | 48.53 | 616 / 1335 | 0% | 0 | 0 / 0 |
heart | 30% | 18.82 | 260 / 861 | 0% | 0 | 0 / 0 |
brain | 25% | 431.54 | 669 / 2642 | 5% | 0.14 | 34 / 705 |
muscle | 2% | 0.99 | 15 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010002 | Biological process | cardioblast differentiation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0001829 | Biological process | trophectodermal cell differentiation |
GO_0002302 | Biological process | CD8-positive, alpha-beta T cell differentiation involved in immune response |
GO_0001764 | Biological process | neuron migration |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0043433 | Biological process | negative regulation of DNA-binding transcription factor activity |
GO_0006338 | Biological process | chromatin remodeling |
GO_0048708 | Biological process | astrocyte differentiation |
GO_0021772 | Biological process | olfactory bulb development |
GO_0048382 | Biological process | mesendoderm development |
GO_0002250 | Biological process | adaptive immune response |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0001707 | Biological process | mesoderm formation |
GO_0019827 | Biological process | stem cell population maintenance |
GO_0021796 | Biological process | cerebral cortex regionalization |
GO_0060809 | Biological process | mesodermal to mesenchymal transition involved in gastrulation |
GO_0007420 | Biological process | brain development |
GO_0060706 | Biological process | cell differentiation involved in embryonic placenta development |
GO_0001706 | Biological process | endoderm formation |
GO_0010467 | Biological process | gene expression |
GO_0035914 | Biological process | skeletal muscle cell differentiation |
GO_0021895 | Biological process | cerebral cortex neuron differentiation |
GO_0001714 | Biological process | endodermal cell fate specification |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0031490 | Molecular function | chromatin DNA binding |
Gene name | EOMES |
Protein name | Eomesodermin homolog (T-box brain protein 2) (T-brain-2) (TBR-2) |
Synonyms | TBR2 |
Description | FUNCTION: Functions as a transcriptional activator playing a crucial role during development. Functions in trophoblast differentiation and later in gastrulation, regulating both mesoderm delamination and endoderm specification. Plays a role in brain development being required for the specification and the proliferation of the intermediate progenitor cells and their progeny in the cerebral cortex. Also involved in the differentiation of CD8+ T-cells during immune response regulating the expression of lytic effector genes. . |
Accessions | ENST00000449599.4 [O95936-4] ENST00000295743.8 [O95936-1] ENST00000461503.2 [O95936-3] O95936 |